Detalhe da pesquisa
1.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 352-358, 2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239634
2.
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Pediatrics
; 151(5)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026401
3.
Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations.
Am J Public Health
; 102(2): e15-21, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22390457
4.
Vaccination Coverage of Adolescents With Chronic Medical Conditions.
Am J Prev Med
; 53(5): 680-688, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28928039
5.
Timeliness of 2009 H1N1 vaccine coverage in a low-income pediatric and adolescent population.
Vaccine
; 31(16): 2103-7, 2013 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21458606